Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis

The current Multiple Sclerosis (MS) therapeutic landscape is rapidly growing. Glatiramer acetate (GA) remains unique given its non-immunosuppressive mechanism of action as well as its superior long-term safety and sustained efficacy data. In this review, we discuss proposed mechanisms of action of G...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Boster, Aaron, Bartoszek, Mary Pat, O’Connell, Colleen, Pitt, David, Racke, Michael
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2011
Témata:
Reviews
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3187678/
https://ncbi.nlm.nih.gov/pubmed/22010043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285611422108
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky